• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于网络药理学和分子对接的对毛脉鼠尾草和莲心碱中抗冠心病生物活性化合物的分析

Network Pharmacology and Molecular Docking-Based Analysis on Bioactive Anticoronary Heart Disease Compounds in Maxim and Macrostemi.

作者信息

Yu Yi-Ding, Hou Wang-Jun, Zhang Juan, Xue Yi-Tao, Li Yan

机构信息

Shandong University of Traditional Chinese Medicine, Jinan 250014, China.

Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250014, China.

出版信息

Evid Based Complement Alternat Med. 2021 Nov 16;2021:6704798. doi: 10.1155/2021/6704798. eCollection 2021.

DOI:10.1155/2021/6704798
PMID:34824593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8610662/
Abstract

Maxim. and Macrostemi are the components of Gualou Xiebai decoction (GLXB), a commonly used herbal combination for the treatment of coronary heart disease (CHD) in traditional Chinese medicine. Although GLXB is associated with a good clinical effect, its active compounds and mechanism of action remain unclear, which limits its clinical application and the development of novel drugs. In this study, we explored key compounds, targets, and mechanisms of action for GLXB in the treatment of CHD using the network pharmacology approach. We identified 18 compounds and 21 action targets via database screening. Enrichment analysis indicated that the effects of GLXB in patients with CHD are primarily associated with the regulation of signalling pathways for tumour necrosis factor, nuclear factor-kappa B, hypoxia-inducible factor-1, arachidonic acid metabolism, and insulin resistance. GLXB thus exerts anti-inflammatory, antihypoxic, and antiagglutinating effects; regulates lipid metabolism; and combats insulin resistance in CHD via these pathways, respectively. After reverse targeting, we observed that the main active compounds of GLXB in the treatment of CHD were quercetin, naringenin, -sitosterol, ethyl linolenate, ethyl linoleate, and prostaglandin B1. To explore the potential of these compounds in the treatment of CHD, we verified the affinity of the compounds and targets via molecular docking analysis. Our study provides a bridge for the transformation of natural herbs and molecular compounds into novel drug therapies for CHD.

摘要

瓜蒌和薤白是瓜蒌薤白汤(GLXB)的组成成分,瓜蒌薤白汤是中医治疗冠心病(CHD)常用的草药组合。尽管瓜蒌薤白汤具有良好的临床疗效,但其活性成分和作用机制仍不明确,这限制了其临床应用和新药研发。在本研究中,我们采用网络药理学方法探索瓜蒌薤白汤治疗冠心病的关键化合物、靶点及作用机制。通过数据库筛选,我们鉴定出18种化合物和21个作用靶点。富集分析表明,瓜蒌薤白汤对冠心病患者的作用主要与肿瘤坏死因子、核因子-κB、缺氧诱导因子-1、花生四烯酸代谢和胰岛素抵抗的信号通路调节有关。因此,瓜蒌薤白汤分别通过这些途径发挥抗炎、抗缺氧和抗凝集作用;调节脂质代谢;并对抗冠心病中的胰岛素抵抗。反向靶向分析后,我们观察到瓜蒌薤白汤治疗冠心病的主要活性化合物为槲皮素、柚皮素、β-谷甾醇、亚麻酸乙酯、亚油酸乙酯和前列腺素B1。为了探索这些化合物在治疗冠心病中的潜力,我们通过分子对接分析验证了化合物与靶点的亲和力。我们的研究为天然草药和分子化合物转化为治疗冠心病的新型药物疗法提供了一座桥梁。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbee/8610662/469962faa695/ECAM2021-6704798.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbee/8610662/bef4f597a7ca/ECAM2021-6704798.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbee/8610662/54afc173ca38/ECAM2021-6704798.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbee/8610662/8f1629ea34fa/ECAM2021-6704798.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbee/8610662/469962faa695/ECAM2021-6704798.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbee/8610662/bef4f597a7ca/ECAM2021-6704798.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbee/8610662/54afc173ca38/ECAM2021-6704798.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbee/8610662/8f1629ea34fa/ECAM2021-6704798.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbee/8610662/469962faa695/ECAM2021-6704798.004.jpg

相似文献

1
Network Pharmacology and Molecular Docking-Based Analysis on Bioactive Anticoronary Heart Disease Compounds in Maxim and Macrostemi.基于网络药理学和分子对接的对毛脉鼠尾草和莲心碱中抗冠心病生物活性化合物的分析
Evid Based Complement Alternat Med. 2021 Nov 16;2021:6704798. doi: 10.1155/2021/6704798. eCollection 2021.
2
Discovery of the mechanisms and major bioactive compounds responsible for the protective effects of Gualou Xiebai Decoction on coronary heart disease by network pharmacology analysis.网络药理学分析发现瓜蒌薤白半夏汤防治冠心病的作用机制及主要活性成分。
Phytomedicine. 2019 Mar 15;56:261-268. doi: 10.1016/j.phymed.2018.11.010. Epub 2018 Nov 8.
3
Deciphering the combination mechanisms of Gualou-Xiebai herb pair against atherosclerosis by network pharmacology and HPLC-Q-TOF-MS technology.基于网络药理学和HPLC-Q-TOF-MS技术解析瓜蒌薤白药对抗动脉粥样硬化的配伍机制
Front Pharmacol. 2022 Sep 1;13:941400. doi: 10.3389/fphar.2022.941400. eCollection 2022.
4
Network pharmacology analysis and experimental verification of the antithrombotic active compounds of trichosanthis pericarpium (Gualoupi) in treating coronary heart disease.栝楼皮抗冠心病血栓活性成分的网络药理学分析与实验验证
J Ethnopharmacol. 2024 Jul 15;329:118158. doi: 10.1016/j.jep.2024.118158. Epub 2024 Apr 13.
5
Revealing the mechanism of Gualou-Xiebai against myocardial ischemia based on network pharmacology and energy metabolism strategies.基于网络药理学和能量代谢策略揭示瓜蒌薤白防治心肌缺血的作用机制。
Biomed Chromatogr. 2024 Dec;38(12):e6007. doi: 10.1002/bmc.6007. Epub 2024 Sep 26.
6
Discovery of cardio-protective constituents of Gualou Xiebai Decoction, a classical traditional Chinese medicinal formula.发现瓜蒌薤白汤这一经典中药方剂的心脏保护成分。
Phytomedicine. 2019 Feb 15;54:318-327. doi: 10.1016/j.phymed.2018.04.047. Epub 2018 Apr 18.
7
Mechanism of Baihe Decoction in the treatment of coronary heart disease based on network pharmacology and molecular docking.基于网络药理学和分子对接的百合汤治疗冠心病的机制
Ann Palliat Med. 2021 Mar;10(3):3205-3218. doi: 10.21037/apm-21-543.
8
Metabolites profile of Gualou Xiebai Baijiu decoction (a classical traditional Chinese medicine prescription) in rats by ultra-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry.基于超高效液相色谱-四极杆飞行时间串联质谱联用技术的瓜蒌薤白白酒汤(一种经典中药方剂)在大鼠体内的代谢产物谱分析
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 May 15;1085:72-88. doi: 10.1016/j.jchromb.2018.04.001. Epub 2018 Apr 4.
9
Qualitative and quantitative analysis of the chemical profile for Gualou-Xiebai-Banxia decoction, a classical traditional Chinese medicine formula for the treatment of coronary heart disease, by UPLC-Q/TOF-MS combined with chemometric analysis.采用 UPLC-Q/TOF-MS 结合化学计量学分析方法对治疗冠心病的经典中药方剂瓜蒌薤白半夏汤的化学成分进行定性和定量分析。
J Pharm Biomed Anal. 2021 Apr 15;197:113950. doi: 10.1016/j.jpba.2021.113950. Epub 2021 Feb 3.
10
Integration of metabolomics and transcriptomics to reveal anti-chronic myocardial ischemia mechanism of Gualou Xiebai decoction.整合代谢组学和转录组学揭示瓜蒌薤白汤抗慢性心肌缺血的作用机制。
J Ethnopharmacol. 2022 Oct 28;297:115530. doi: 10.1016/j.jep.2022.115530. Epub 2022 Jul 10.

引用本文的文献

1
A Comprehensive Review on Potential In Silico Screened Herbal Bioactive Compounds and Host Targets in the Cardiovascular Disease Therapy.关于潜在的计算机筛选的草药生物活性化合物和心血管疾病治疗中的宿主靶点的全面综述。
Biomed Res Int. 2024 Oct 29;2024:2023620. doi: 10.1155/2024/2023620. eCollection 2024.
2
Sour Tamarind Is More Antihypertensive than the Sweeter One, as Evidenced by In Vivo Biochemical Indexes, Ligand-Protein Interactions, Multitarget Interactions, and Molecular Dynamic Simulation.酸罗望子比甜罗望子具有更强的降压作用,这可以从体内生化指标、配体-蛋白相互作用、多靶相互作用和分子动力学模拟得到证明。
Nutrients. 2023 Jul 31;15(15):3402. doi: 10.3390/nu15153402.
3

本文引用的文献

1
To Explore the Mechanism and Equivalent Molecular Group of Fuxin Mixture in Treating Heart Failure Based on Network Pharmacology.基于网络药理学探讨复心合剂治疗心力衰竭的作用机制及等效分子组
Evid Based Complement Alternat Med. 2020 Nov 21;2020:8852877. doi: 10.1155/2020/8852877. eCollection 2020.
2
HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine.中草药:一个基于高通量实验和参考指导的中草药数据库。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1197-D1206. doi: 10.1093/nar/gkaa1063.
3
N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects.
Systematic Elaboration of the Pharmacological Targets and Potential Mechanisms of ZhiKe GanCao Decoction for Preventing and Delaying Intervertebral Disc Degeneration.
枳壳甘草汤防治和延缓椎间盘退变的药理靶点及潜在机制的系统阐述
Evid Based Complement Alternat Med. 2022 Apr 22;2022:8786052. doi: 10.1155/2022/8786052. eCollection 2022.
一项比较他汀类药物、安慰剂或不治疗以评估副作用的单病例试验。
N Engl J Med. 2020 Nov 26;383(22):2182-2184. doi: 10.1056/NEJMc2031173. Epub 2020 Nov 15.
4
An update on β-sitosterol: A potential herbal nutraceutical for diabetic management.β-谷固醇:一种用于糖尿病管理的有潜力的植物性营养补充剂的最新研究进展。
Biomed Pharmacother. 2020 Nov;131:110702. doi: 10.1016/j.biopha.2020.110702. Epub 2020 Aug 31.
5
Molecular machinery and interplay of apoptosis and autophagy in coronary heart disease.冠心病中细胞凋亡与自噬的分子机制及其相互作用。
J Mol Cell Cardiol. 2019 Nov;136:27-41. doi: 10.1016/j.yjmcc.2019.09.001. Epub 2019 Sep 7.
6
Interplay of TNF-α, soluble TNF receptors and oxidative stress in coronary chronic total occlusion of the oldest patients with coronary heart disease.TNF-α、可溶性 TNF 受体与氧化应激在老年冠心病慢性完全闭塞病变中的相互作用
Cytokine. 2020 Jan;125:154836. doi: 10.1016/j.cyto.2019.154836. Epub 2019 Sep 5.
7
β-Sitosterol Attenuates the Intracranial Aneurysm Growth by Suppressing TNF-α-Mediated Mechanism.β-谷甾醇通过抑制 TNF-α 介导的机制来减轻颅内动脉瘤的生长。
Pharmacology. 2019;104(5-6):303-311. doi: 10.1159/000502221. Epub 2019 Aug 30.
8
Nrf2, NF-κB and PPARβ/δ mRNA Expression Profile in Patients with Coronary Artery Disease.Nrf2、NF-κB 和 PPARβ/δ 在冠心病患者中的 mRNA 表达谱。
Arq Bras Cardiol. 2019 Dec;113(6):1121-1127. doi: 10.5935/abc.20190125.
9
Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr mice.柚皮苷可促进 LDLR 小鼠的动脉粥样硬化消退。
Atherosclerosis. 2019 Jul;286:60-70. doi: 10.1016/j.atherosclerosis.2019.05.009. Epub 2019 May 9.
10
Promotion of PTEN on apoptosis through PI3K/Akt signal in vascular smooth muscle cells of mice model of coronary heart disease.促进 PTEN 通过 PI3K/Akt 信号诱导冠心病小鼠模型血管平滑肌细胞凋亡。
J Cell Biochem. 2019 Sep;120(9):14636-14644. doi: 10.1002/jcb.28725. Epub 2019 May 15.